We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stericycle (SRCL) Stock Drops 3% Since Q4 Earnings Release
Read MoreHide Full Article
Stericycle, Inc.’s (SRCL - Free Report) fourth-quarter 2022 earnings matched the Zacks Consensus Estimate while revenues missed the same.
The stock declined 3% since the earnings release on Feb 23 as EPS guidance for 2023 was weak. The company expects adjusted EPS to be between $1.75 and $2.05, lower than the current Zacks Consensus Estimate of $2.36.
The stock has declined 18.9% over the past year compared with the 0.7% decline of the industry it belongs to.
Quarterly EPS came in at 60 cents and increased 57.9% year over year. Revenues of $670.4 million missed the consensus mark by 3.9% but increased 2% year over year. Organic revenues increased 5.7% year over year.
Revenues by Service
Regulated Waste and Compliance Services revenues declined 1.4% year over year on a reported basis but increased 2.8% on an organic basis to $449.3 million. Secure Information Destruction revenues increased 9.7% year over year on a reported basis and 12.2% organically to $221.1 million.
Revenues by Geography
Revenues from North America were $565.9 million, up 5.5% year over year on a reported basis and 7.6% organically. International revenues of $104.5 million declined 13.7% year over year on a reported basis and 2.6% organically.
Profitability Performance
Adjusted EBITDA was $117.6 million, up 27.4% from the year-ago quarter’s figure. The adjusted EBITDA margin was 17.5%, up from 14% in the prior-year quarter.
Adjusted operating income in the quarter amounted to $90.6 million, up 41.1% from the year-ago quarter’s levels. Adjusted operating margin was 13.5%, up from 9.8% in the prior-year quarter.
Balance Sheet & Cash Flow
Stericycle exited the quarter with cash and cash equivalents of $56 million compared with $44 million at the end of the prior quarter. Long-term debt was $1.5 billion compared with $1.7 billion in the prior quarter.
SRCL generated $157.1 million of net cash from operating activities while capex was $26.2 million in the quarter. Free cash flow came in at $130.9 million in the reported quarter.
2023 Outlook
Stericycle expects 3-5% revenue growth organically. The company expects free cash flow to be between $175 million and $205 million. It anticipates capital expenditures between $125 million and $145 million.
Performances of Some Other Business Services Companies
Robert Half International Inc. (RHI - Free Report) reported mixed fourth-quarter 2022 results, wherein earnings beat the Zacks Consensus Estimate but revenues missed the same.
RHI’s quarterly earnings of $1.37 per share beat the Zacks Consensus Estimate by 1.5% but declined 9.3% year over year. Revenues of $1.73 billion missed the Zacks Consensus Estimate by 0.6% and decreased 2.4% year over year.
Automatic Data Processing, Inc. (ADP - Free Report) reported better-than-expected second-quarter fiscal 2023 results.
ADP’s adjusted earnings per share of $1.96 beat the Zacks Consensus Estimate by 0.5% and grew 19% from the year-ago fiscal quarter. Total revenues of $4.4 billion beat the Zacks Consensus Estimate by 0.3% and improved 9.1% from the year-ago fiscal quarter.
Booz Allen Hamilton Holding Corp. (BAH - Free Report) reported impressive third-quarter fiscal 2023 results, wherein both earnings and revenues beat the respective Zacks Consensus Estimate. Quarterly adjusted earnings per share of $1.07 beat the Zacks Consensus Estimate by 4.9% and increased 4.9% on a year-over-year basis.
BAH’s total revenues of $2.3 billion beat the Zacks Consensus Estimate by 4% and increased 12.1% on a year-over-year basis.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stericycle (SRCL) Stock Drops 3% Since Q4 Earnings Release
Stericycle, Inc.’s (SRCL - Free Report) fourth-quarter 2022 earnings matched the Zacks Consensus Estimate while revenues missed the same.
The stock declined 3% since the earnings release on Feb 23 as EPS guidance for 2023 was weak. The company expects adjusted EPS to be between $1.75 and $2.05, lower than the current Zacks Consensus Estimate of $2.36.
The stock has declined 18.9% over the past year compared with the 0.7% decline of the industry it belongs to.
Stericycle, Inc. Price
Stericycle, Inc. price | Stericycle, Inc. Quote
Quarterly EPS came in at 60 cents and increased 57.9% year over year. Revenues of $670.4 million missed the consensus mark by 3.9% but increased 2% year over year. Organic revenues increased 5.7% year over year.
Revenues by Service
Regulated Waste and Compliance Services revenues declined 1.4% year over year on a reported basis but increased 2.8% on an organic basis to $449.3 million. Secure Information Destruction revenues increased 9.7% year over year on a reported basis and 12.2% organically to $221.1 million.
Revenues by Geography
Revenues from North America were $565.9 million, up 5.5% year over year on a reported basis and 7.6% organically. International revenues of $104.5 million declined 13.7% year over year on a reported basis and 2.6% organically.
Profitability Performance
Adjusted EBITDA was $117.6 million, up 27.4% from the year-ago quarter’s figure. The adjusted EBITDA margin was 17.5%, up from 14% in the prior-year quarter.
Adjusted operating income in the quarter amounted to $90.6 million, up 41.1% from the year-ago quarter’s levels. Adjusted operating margin was 13.5%, up from 9.8% in the prior-year quarter.
Balance Sheet & Cash Flow
Stericycle exited the quarter with cash and cash equivalents of $56 million compared with $44 million at the end of the prior quarter. Long-term debt was $1.5 billion compared with $1.7 billion in the prior quarter.
SRCL generated $157.1 million of net cash from operating activities while capex was $26.2 million in the quarter. Free cash flow came in at $130.9 million in the reported quarter.
2023 Outlook
Stericycle expects 3-5% revenue growth organically. The company expects free cash flow to be between $175 million and $205 million. It anticipates capital expenditures between $125 million and $145 million.
Currently, Stericycle carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performances of Some Other Business Services Companies
Robert Half International Inc. (RHI - Free Report) reported mixed fourth-quarter 2022 results, wherein earnings beat the Zacks Consensus Estimate but revenues missed the same.
RHI’s quarterly earnings of $1.37 per share beat the Zacks Consensus Estimate by 1.5% but declined 9.3% year over year. Revenues of $1.73 billion missed the Zacks Consensus Estimate by 0.6% and decreased 2.4% year over year.
Automatic Data Processing, Inc. (ADP - Free Report) reported better-than-expected second-quarter fiscal 2023 results.
ADP’s adjusted earnings per share of $1.96 beat the Zacks Consensus Estimate by 0.5% and grew 19% from the year-ago fiscal quarter. Total revenues of $4.4 billion beat the Zacks Consensus Estimate by 0.3% and improved 9.1% from the year-ago fiscal quarter.
Booz Allen Hamilton Holding Corp. (BAH - Free Report) reported impressive third-quarter fiscal 2023 results, wherein both earnings and revenues beat the respective Zacks Consensus Estimate. Quarterly adjusted earnings per share of $1.07 beat the Zacks Consensus Estimate by 4.9% and increased 4.9% on a year-over-year basis.
BAH’s total revenues of $2.3 billion beat the Zacks Consensus Estimate by 4% and increased 12.1% on a year-over-year basis.